| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032787 |
| Receipt No. | R000037397 |
| Official scientific title of the study | A study for safety evaluation of excess consumption of test food. |
| Date of disclosure of the study information | 2018/05/31 |
| Last modified on | 2018/10/04 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A study for safety evaluation of excess consumption of test food. | |
| Title of the study (Brief title) | A study for safety evaluation of excess consumption of test food. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To identify the safety of the test food to consume 5 times more than recommended daily intake |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | conduct examinations and tests at 0 week and at 2 and 4 weeks.
Hematology test Blood biochemistry test Urinalysis Blood pressure/pulsation Body weight Doctor's questions Adverse event |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral intake of the test foods (10 tabrets in a day for 4 weeks) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy adults aged 20 to 80 years old.
2) Gender: No preference 3) Subjects without smoking habits 4) Subjects who do not have a habit of taking a meal containing a large amount of the tested food 5) Subjects who do not suffer from lifestyle diseases (high blood pressure, diabetes etc.), rheumatism, liver disorders, renal disorders, other chronic diseases 6) Subjects who have no history of treatment of malignant tumor, heart failure, myocardial infarction 7) Subjects who have no history of allergy to test foods / mushrooms, medicines 8) Subjects who do not take medication for Outpatient treatment 9) Subjects who do not regularly use health foods 10) Subjects giving written informed consent |
|||
| Key exclusion criteria | 1) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period
2) Subjects who are participating the other clinical tests. Subjects who participated within 3-month prior to the current study 3) Subjects who do not comply with instructions from the doctor or medical staff 4) Others who have been determined ineligible by investigator |
|||
| Target sample size | 12 | |||
| Research contact person | |
| Name of lead principal investigator | Naotaka Hashiya |
| Organization | Kanyukai clinic |
| Division name | Head |
| Address | 2-12-24 Tamagawa Fukushima-ku,Osaka-shi,Osaka,553-0004,Japan |
| TEL | 06-6444-7788 |
| hashiya@carna-medsalon.jp | |
| Public contact | |
| Name of contact person | Taisuke Fukaya |
| Organization | Tashikani Plus Co., Ltd |
| Division name | CEO |
| Address | 6F 2-2-27 Tenjinbashi Kita-ku,Osaka-shi,Osaka,530-0041,Japan |
| TEL | 06-6352-6622 |
| Homepage URL | |
| fukaya@tashikani.jp | |
| Sponsor | |
| Institute | Tashikani Plus Co., Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | non-disclosure |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037397 |